MLchartDataset catalogue

Wistar rabies virus strain PM-1503-3M vaccine

Term · Oncology and biomedicine · MLC-T-ONC-017564

A vaccine containing inactivated Wistar rabies virus strain PM-1503-3M, with immunotherapeutic activity. Upon administration, Wistar rabies virus strain PM-1503-3M vaccine induces the formation of rabies-specific antibodies and rabies virus neutralizing antibodies (RVNA), which provide protection against rabies infection. This rabies vaccine can be used for both pre-exposure and post-exposure prophylaxis of rabies.

Table 1. Record
IdentifierMLC-T-ONC-017564
FieldOncology and biomedicine
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-017564",
  "term": "Wistar rabies virus strain PM-1503-3M vaccine",
  "field": "Oncology and biomedicine",
  "definition": "A vaccine containing inactivated Wistar rabies virus strain PM-1503-3M, with immunotherapeutic activity. Upon administration, Wistar rabies virus strain PM-1503-3M vaccine induces the formation of rabies-specific antibodies and rabies virus neutralizing antibodies (RVNA), which provide protection against rabies infection. This rabies vaccine can be used for both pre-exposure and post-exposure prophylaxis of rabies.",
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/wistar-rabies-virus-strain-pm-1503-3m-vaccine/"
}

Record 17,438 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.